ArticleJournal of molecular modeling2026
Mechanisms of the binding of camptothecin derivatives with topoisomerase I: Molecular docking, molecular dynamics simulations, and binding free energy calculations.
Article in Journal of molecular modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextTopoisomerase 1 (TOP1) is a key anticancer target, and camptothecin (CPT) and its derivatives are typical TOP1 inhibitors. Among them, the 7-aminourea and 7-aminothiourea derivatives of CPT (XSJ07 and XSJ05, respectively) exhibit potent inhibitory activity, yet their binding mechanisms remain unclear. In this study, we investigated the interactions of XSJ05 and XSJ07 with TOP1 to clarify their molecular recognition behavior. Both compounds intercalated into the cleaved-DNA-binding site to form stable TOP1-DNA-ligand ternary complexes. The calculated binding free energies of the XSJ05/TOP1 and XSJ07/TOP1 systems were -58.34 and -51.60 kcal/mol, respectively. These findings provide mechanistic insights into the binding of CPT derivatives to TOP1 and may guide the rational design of novel CPT-based inhibitors.
methodsMolecular docking, molecular dynamics (MD) simulations, and binding free energy calculations were employed to characterize the interactions of XSJ05 and XSJ07 with TOP1. Ligand structures were optimized at the B3LYP/6-311++G(d,p) level, and partial atomic charges were derived using the RESP protocol based on HF/6-31G calculations in Gaussian 16. Docking was performed using AutoDock 4.2 with grid parameters defined from the TPT/TOP1 crystal structure. MD simulations of the ligand-TOP1-DNA ternary complexes were conducted using AMBER24 with the ff19SB force field for TOP1 and DNA, GAFF2 for the ligands, and explicit TIP3P water. Each system was equilibrated and simulated for 500 ns in triplicate. Binding free energies and per-residue energy decompositions were calculated using the MM/GBSA method implemented in AMBER Tools, with analysis performed using the CPPTRAJ module.
Indexed as
Identifiers
42418033What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.